Expression of CYP3A4 as a predictor of response to chemotherapy in peripheral T-cell lymphomas
Cristina Rodríguez‐Antona(Instituto de Salud Carlos III), Beatriz Martínez–Delgado(Centre for Biomedical Network Research on Rare Diseases), Susanna Leskelä(Spanish National Cancer Research Centre), Marta Cuadros(Hospital Universitario La Paz), Javier Benı́tez(Spanish National Cancer Research Centre), Javier Alves(Hospital Universitario La Paz), Maria Victoria Moneo, Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Amancio Carnero(Instituto de Salud Carlos III), Juan C. Cigudosa(Centro Nacional de Epidemiología), M Zajaç(National Cancer Centre Japan), Carmen Alonso-Martín(Spanish National Cancer Research Centre)
Cited by 48
Related Papers
Association analysis identifies 65 new breast cancer risk loci
|Nature|2017|1.6k
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
|The American Journal of Human Genetics|2018|1.2k
Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk
|Nature Genetics|2017|642
Glycolytic Enzymes Can Modulate Cellular Life Span
|Cancer Research|2005|640